UNC Lineberger News

Drug That Inhibits Vascular Development Does Not Help Colon Cancer Survival

In a study published this month in the Journal of Clinical Oncology, the results of a clinical trial of the drug bevacizumab to treat colon cancer in combination with the standard therapy found that the drug did not significantly increase disease-free survival in patients with stage II and stage III colon cancer.

Drug That Inhibits Vascular Development Does Not Help Colon Cancer Survival - Read More…